TABLE 1.
Characteristics of mammography cohort
All patients N = 198,278 |
|
---|---|
N (%) or Mean (SD) | |
Age at screening (years) | 54.30 (11.04) |
Age at screening (categories) | |
40–49 | 80,416 (40.6%) |
50–59 | 57,717 (29.1%) |
60–69 | 38,641 (19.5%) |
70+ | 21,504 (10.8%) |
Prior biopsies | |
0 | 176,549 (89.0%) |
1 | 17,168 (8.7%) |
2 or more | 4561 (2.3%) |
Atypical hyperplasia | 1734 (0.9%) |
Age at menarche | |
<12 | 31,802 (16.0%) |
12–13 | 99,978 (50.4%) |
14+ | 47,558 (24.0%) |
Missing | 18,940 (9.6%) |
Age at first live birth | |
No births | 42,217 (21.3%) |
Under 20 | 20,123 (10.1%) |
20–24 | 36,625 (18.5%) |
25–29 | 41,524 (20.9%) |
30 or older | 46,077 (23.2%) |
Missing | 11,712 (5.9%) |
Number of relatives with breast cancer | |
0 | 173,075 (87.3%) |
1 | 22,969 (11.6%) |
2+ | 2234 (1.1%) |
Race/ethnicity | |
White | 146,159 (73.7%) |
Black/African American | 29,822 (15.0%) |
Hispanic/Latino | 6585 (3.3%) |
Asian/Pacific Islander | 9371 (4.7%) |
Other/unknown | 6341 (3.2%) |
BMI | |
<25 | 76,035 (38.3%) |
25–29.9 | 49,461 (24.9%) |
30+ | 49,484 (25.0%) |
Missing | 23,298 (11.8%) |
Postmenopausal | 115,405 (58.2%) |
Number of live births | |
0 | 42,217 (21.3%) |
1 | 41,269 (20.8%) |
2 | 52,116 (26.3%) |
3 | 28,054 (14.1%) |
4+ | 16,032 (8.1%) |
Missing | 18,590 (9.4%) |
BI‐RADS breast density | |
BI‐RADS A | 15,348 (7.7%) |
BI‐RADS B | 76,196 (38.4%) |
BI‐RADS C | 87,459 (44.1%) |
BI‐RADS D | 15,740 (7.9%) |
Unknown | 3535 (1.8%) |
Site | |
MGH | 79,671 (40.2%) |
NWH | 52,331 (26.4%) |
Penn | 66,276 (33.4%) |
Breast cancers | |
DCIS | 1158 (22.4%) |
Total invasive | 4002 (77.6%) |
Invasive ER/PR+HER2− | 3077 (76.9%) |
Invasive triple negative | 300 (7.5%) |
Invasive ER/PR+HER2+ | 342 (8.5%) |
Invasive ER/PR−HER2+ | 126 (3.2%) |
Invasive missing | 157 (3.9%) |
Abbreviations: ER/PR, estrogen receptor/progesterone receptor; HER2, human epidermal growth factor receptor 2; MGH, Massachusetts General Hospital; NWH, Newton‐Wellesley Hospital.